Endocrine Abstracts

Objective: The objectives of this study were to determine the prevalence of diagnosed and undiagnosed diabetes mellitus (DM), prediabetes and to evaluate the associated risk factors in the sample of adult Turkish population.Methods: A total of 4000 eligible study subjects aged 20 years or older, chosen by multistage sampling on a field were selected. Of those 3721 subjects (2139 women and 1582 men) participated in the study. The study was performed betwe...

Introduction: The aim of this study was to validate the American Thyroid Association (ATA) risk of recurrence staging system (2009).Methods: Retrospective analysed 300 adult (239 women, 61 men) differentiated thyroid cancer patients followed for a median of 57 months (range 38–97).Results: ATA risk stratification of patients according to the system 54.7% low-risk, 39.7% moderate risk, and 5.7% were in the high risk group. The ...

Background: Adrenal carcinoma is rare endocrine cancer. Survival time is short and primary treatment is surgery.Methods: Four patients with histopathologically diagnosed as adrenal carcinoma between 2007 and 2013 were evaluated retrospectively.Results: Two of the patients were female and others were male. Their ages were 39, 50, 55 and 61 respectively. All the patients were admitted to the hospital with abdominal pain. Tumor diamet...

Introduction: Deposition of amyloid substance within the thyroid gland causing clinically appearent enlargement of the gland is described as amyloid goiter. Although microscopic deposition of amyloid substance in thyroid gland is common in systemic amyloidosis, occurence of amyloid goiter is rare.Case: A 55 years old male patient, who had been diagnosed with multinodular goiter for 10 years, was admitted to our clinic with complaint of increased swelling...

Aims/IntroductionWe aimed to see whether Insulin Glargine U300 can provide better blood glucose control while reducing hypoglycemia in a more homogeneous population compared to previous studies.Materials and methodsFor evaluation of FBG, HbA1c and weight at 6 months and all variables final, observation windows of 120–240 days (4–8 months) and 240–480 days (9–16 months) after Insulin Glargi...